1. Mechanical Circulatory Support and Heart Transplantation: Donor and Recipient Factors Influencing Graft Survival 
Simon Maltais, MD, PhD, Nikhil P. Jaik, MD, Irene D. Feurer, PhD, Mark A. Wigger, MD, Thomas G. DiSalvo, MD, Kelly H. Schlendorf, MD, Rashid M. Ahmad, MD, Daniel J. Lenihan, MD, John M. Stulak, MD, Mary E. Keebler, MD 
The Annals of Thoracic Surgery 
Volume 96, Issue 4, Pages (October 2013)
DOI: /j.athoracsur
Copyright © 2013 The Society of Thoracic Surgeons Terms and Conditions

2. Fig 1
Overall Kaplan-Meier graft survival is shown for 2,785 patients with orthotopic heart transplantation and mechanical circulatory support explantation. Median graft survival was 95 months (95% confidence interval [CI]: 77 to 114 months). Graft survival at 1, 3, and 5 years was 88%, 81%, and 73%, respectively.
The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur )
Copyright © 2013 The Society of Thoracic Surgeons Terms and Conditions

3. Fig 2
Overall graft survival is shown for mechanical circulatory support device by type of left ventricular assist device (LVAD) and total artificial heart (TAH). LVADs included HeartMate XVE, HeartMate II, and HeartWare. Explanted LVAD type at the time of heart transplantation did not influence graft survival (all pairwise p > 0.168), whereas TAH explant was associated with decrease graft survival compared with LVAD explant (all p < vs LVADs).
The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur )
Copyright © 2013 The Society of Thoracic Surgeons Terms and Conditions

4. Fig 3
Graft survival is shown for the three donor-to-recipient categories of body mass index (BMI) ratio (< 0.8, 0.8 to 1.2, and > 1.2). Graft survival after mechanical circulatory support explant was significantly decreased when the donor-to-recipient BMI ratio was less than 0.8 compared with a ratio exceeding 1.2 (p = 0.035).
The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur )
Copyright © 2013 The Society of Thoracic Surgeons Terms and Conditions